David P Luci, a director of Dipexium Pharmaceuticals, Inc., just received 275,000 options from the company. The strike price of the options received was $1.80, and these expire on dates ranging from March 18, 2019 to January 17, 2022. Luci now owns at least 275,000 options on the company.
Some additional info was provided as follows:
Does not reflect 1-for-8 reverse split effected with respect to common stock of PLx Pharma Inc. (formerly Dipexium Pharmaceuticals, Inc.) (the "Company") on April 18, 2017.
Option to purchase shares of common stock vested with respect to 137,500 shares on January 17, 2017, and with respect remaining 137,500 shares in connection with the merger (the "Merger") of a wholly-owned subsidiary of the Company with and into PLx Opco Inc. (fo
rmerly PLx Pharma Inc.).
Option to purchase shares of common stock cancelled by mutual agreement of the reporting person and the Company in connection with the Merger.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Dipexium Pharmaceuticals, Inc. makes a similar move, sign up!
Other recent filings from the company include the following:
Regulation FD - Jan. 8, 2018